Concepedia

Publication | Open Access

Initial human experience with MK‐462 (rizatriptan): a novel 5=HT<sub>ID</sub> agonist

DOIFull Paper Access

51

Citations

21

References

1997

Year

David Sciberras, William J. Polvino, Barry J. Gertz, Haiyung Cheng, Michael Stepanavage, Johanna Wittreich, Timothy Olah, Mark Edwards, Timothy Mant
British Journal of Clinical Pharmacology

Abstract

These results indicate that the novel 5-HT1D agonist, MK-462, is rapidly absorbed following oral administration and warrants further investigation of its utility in the treatment of acute migraine.

References

YearCitations

Page 1